AllianceBernstein
NYMX

AllianceBernstein’s Nymox Pharmaceutical Corp NYMX Stock Holding History

AllianceBernstein’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-10,700
Closed -$38K – 3225
2020
Q2 		$38K Buy
+10,700
New +$33.8K ﹤0.01% 3176
2014
Q2 		– Sell
-207
Closed -$1K – 3683
2014
Q1 		$1K Hold
207
– – ﹤0.01% 3573
2013
Q4 		$1K Hold
207
– – ﹤0.01% 3376
2013
Q3 		$1K Buy
+207
New +$1.35K ﹤0.01% 3391

Other funds holding NYMX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AllianceBernstein's NYMX Position: Q3 2020 in Review

AllianceBernstein sold out of Nymox Pharmaceutical Corp (NYMX) in Q3 2020, closing a stake of 10,700 shares — an estimated $38K sold.

AllianceBernstein first reported a position in NYMX in Q3 2013 and held it in 4 quarters. The position peaked at $38K in Q2 2020. 64 funds tracked by Wall St. Rank hold NYMX as of Q3 2020.

  • AllianceBernstein reported no remaining Nymox Pharmaceutical Corp position as of Q3 2020 after selling out during the quarter.
  • AllianceBernstein sold 10,700 Nymox Pharmaceutical Corp shares in Q3 2020, an estimated $38K.
  • AllianceBernstein first reported a position in Nymox Pharmaceutical Corp in Q3 2013 and held it in 4 quarters.
  • AllianceBernstein's Nymox Pharmaceutical Corp position peaked at $38K in Q2 2020.
  • 64 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q3 2020.

Based on AllianceBernstein's 13F filing for Q3 2020, filed 12 Nov 2020.